Atmo Biosciences
Payments companies reported to CMS as associated with Atmo Biosciences. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Atmo Biosciences, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Atmo Biosciences
These are the largest totals companies reported as associated with Atmo Biosciences. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Eyad Ali | Hampton Bays, NY | Gastroenterology (Internal Medicine) | $750.00 |
| Lincoln Hernandez | New York, NY | Internal Medicine | $152.08 |
| Braden Kuo | New York, NY | Gastroenterology (Internal Medicine) | $142.87 |
| Anne Thai | Burlingame, CA | Gastroenterology (Internal Medicine) | $87.68 |
| Amol Sharma | Augusta, GA | Gastroenterology (Internal Medicine) | $82.62 |
| William Hasler | Ann Arbor, MI | Gastroenterology (Internal Medicine) | $82.62 |
| Chuma Obineme | Summerville, SC | Gastroenterology (Internal Medicine) | $82.62 |
| Nasim Parsa | St Cloud, MN | Gastroenterology (Internal Medicine) | $82.62 |
| Richard Saad | Ann Arbor, MI | Gastroenterology (Internal Medicine) | $82.62 |
| Brian Surjanhata | Boston, MA | Gastroenterology (Internal Medicine) | $60.25 |
Prescribed Atmo Biosciences?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.